Sign In
Buy GLUE
Monte Rosa Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -33.05. In total, the insiders bought 1.56M and sold 1.22M GLUE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-33.05 |
| ● Buy | 1.56M shares |
| ● Sell | 1.22M shares |
|
62% Buy Activity
Moderate Positive Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Mar 02, 2026 Buy |
Dunn Edmund Principal Accounting Officer |
536 Value: $7K |
||
|
Mar 02, 2026 Sell |
Dunn Edmund Principal Accounting Officer |
536 Value: $9K |
||
|
Mar 02, 2026 Buy |
Dunn Edmund Principal Accounting Officer |
536 Value: $7K |
||
|
Feb 27, 2026 Sell |
Dunn Edmund Principal Accounting Officer |
25 164 Value: $455.5K |
||
|
Feb 27, 2026 Buy |
Dunn Edmund Principal Accounting Officer |
25 164 Value: $337.4K |
||
|
Feb 27, 2026 Buy |
Dunn Edmund Principal Accounting Officer |
25 164 Value: $337.4K |
||
|
Feb 23, 2026 Sell |
Janku Filip Chief Medical Officer |
9 189 Value: $179.2K |
||
|
Jan 07, 2026 Sell |
Warmuth Markus President & CEO |
309 Value: $8K |
||
|
Jan 07, 2026 Sell |
Warmuth Markus President & CEO |
1 450 Value: $34.6K |
||
|
Jan 07, 2026 Sell |
Warmuth Markus President & CEO |
3 707 Value: $86.2K |
||
|
Jan 05, 2026 Sell |
Townson Sharon Chief Scientific Officer |
3 155 Value: $47.9K |
||
|
Jan 05, 2026 Sell |
Warmuth Markus President & CEO |
10 135 Value: $153.7K |
||
|
Jan 05, 2026 Sell |
Dunn Edmund Principal Accounting Officer |
1 039 Value: $15.8K |
||
|
Jan 05, 2026 Sell |
Champoux Jennifer Chief Operating Officer |
2 629 Value: $39.9K |
||
|
Jan 05, 2026 Sell |
Nickson Philip Chief Business & Legal Officer |
3 155 Value: $47.9K |
||
|
Jan 05, 2026 Sell |
Janku Filip Chief Medical Officer |
3 155 Value: $47.9K |
||
|
Jan 02, 2026 Buy |
Townson Sharon Chief Scientific Officer |
35 000 Value: $535.9K |
||
|
Jan 02, 2026 Buy |
Janku Filip Chief Medical Officer |
139 000 Value: $2.13M |
||
|
Jan 02, 2026 Buy |
Warmuth Markus President & CEO |
406 000 Value: $6.22M |
||
|
Jan 02, 2026 Buy |
Warmuth Markus President & CEO |
90 000 Value: $1.38M |
||
|
Jan 02, 2026 Buy |
Champoux Jennifer Chief Operating Officer |
35 000 Value: $535.9K |
||
|
Jan 02, 2026 Buy |
Champoux Jennifer Chief Operating Officer |
158 000 Value: $2.42M |
||
|
Jan 02, 2026 Buy |
Nickson Philip Chief Business & Legal Officer |
28 000 Value: $428.7K |
||
|
Jan 02, 2026 Buy |
Nickson Philip Chief Business & Legal Officer |
126 000 Value: $1.93M |
||
|
Jan 02, 2026 Buy |
Janku Filip Chief Medical Officer |
31 000 Value: $474.6K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
